Saffron from Crocus sativus L. (Iridaceae) is getting into focus of medicinal development because of antidepressant
and anticancer activities. Within the present investigation a potential influence
on central receptor systems of ethanolic saffron extract and the crocins was investigated.
While the extract showed no affinity to NMDA receptor binding of the crocin was found
with IC50 10µM. Using sigma-1 receptors a IC50 of 30µM was determined for both, the extract and crocins. No affinity was found against
sigma-2 receptors.
Using saffron for product development a strong need for validated control methods
and use of reference standards is obvious. For that reason methods for isolation of
reference material are described. Crocin-1,-2,-4, cis-crocin-1 and picrocrocin were
isolated in good yields and high purity; identity was proven by NMR and MS. For determination
of crocin distribution analytical RP-18 HPLC method with acetonitrile-TFA as mobile
phase was developed. Using this method the different crocins can be quantified beside
degradation products. Using an RP18 column picrocrocin was quantified from extracts
effectively. Volatile compounds were analyzed by GC-MS, using isophoron, ketosiophoron
and safranal for calibration. For investigation of drying conditions residual enzyme
activity was investigated. All methods were validated. Short time stability was investigated
using crocin-1, indicating sufficient stability of test solutions at RT; degradation
was observed at higher temperatures. A broad investigation using 21 saffron samples
indicated that products from certain proveniences (Spain, Iran, Greece, others) are
not superior to others.